PDS Biotechnology
David Schaaf, MD, serves as Vice President of Medical Affairs at PDS Biotechnology and previously held the same position at Zogenix, Inc. Schaaf has significant experience in Medical Affairs, having served as Senior Director at both Aptevo Therapeutics Inc and Omeros Corporation. Prior roles include Senior Medical Director in US Medical Affairs for Pain at Pfizer, along with positions as Sr. Director, Team Leader for Corporate and Government Customers in Medical Affairs, and Medical Director for Managed Markets Medical. Educational qualifications include a Doctor of Medicine from Columbia University Vagelos College of Physicians and Surgeons and a Bachelor of Science in Chemistry from Stanford University.
This person is not in any offices
PDS Biotechnology
PDS Biotechnology Corporation is a biopharmaceutical company. It develops immunotherapies for cancer and other infectious diseases. It develops products to prevent and treat cervical, ovarian, melanoma, leukemia, pancreatic, oral, multiple myeloma, anal, vulvar, and penile cancers. The company offers PDS0101, a treatment for HPV-related cancers;PDS0102, a pandemic influenza vaccine; and PDS0103, a line of immunotherapy products for non-viral cancers.PDS Biotechnology Corporation was founded in 2005 and is headquartered in North Brunswick, New Jersey.